Twist Bioscience stock rises 1.63% amid NGS sample workflow discussion, Twist Bioscience engages

Traders Union
All News
Business & Wealth
Companies
Twist Bioscience up 1.63% today

Highlights

TWST maintains strong bullish momentum as price trades well above major moving averages amid ongoing technical uptrend.
Short-term indicators flash caution with overbought signals and high weekly volatility, suggesting possible near-term price swings before trend resumes.
Expected range for the coming week is $66.00–$78.00; further upside probable if $72.50 is breached, while $66.00 remains critical support.

The company offered four options: cfDNA (liquid biopsy), FFPE (degraded tumor tissue), low input gDNA, or other. Followers are encouraged to comment their choice.

View post on X Loading...

The tweet was deleted by the author.

But we saved everything 🙂.

Bullish momentum as price holds above key moving averages

TWST is trading at $70.35, which is significantly above the MA-20 ($60.82), MA-50 ($57.26), and MA-200 ($40.93), reflecting sustained bullish momentum across short-, medium-, and long-term timeframes. The Ichimoku Kijun is $64.27, making it immediate support below the current price. Near-term support is clustered at the Ichimoku Kijun ($64.27) and MA-20 ($60.82), with key support further down at MA-50 ($57.26). Resistance is seen at the recent session high ($72.63), while $80.50 (the weekly high and 52-week high) serves as key resistance.

Mixed momentum as overbought signals counter strong trend

Momentum signals on D1 remain constructive, with MACD and ADX both pointing to sustained buyer interest, although oscillators flash caution—RSI sits at 61.88 (moderately bullish), while Stoch RSI and CCI indicate overbought conditions, warning of potential near-term exhaustion. BBP on D1 is strongly positive, showing buyers dominate, and the Awesome Oscillator also confirms upside bias. TWST has risen $1.13, or 0.40%, over the past week, up from the previous close of $69.22. The current price sits in the lower part of this week’s range, with weekly volatility at a high 20.26%. Despite active trading, the price remains well below this week’s peak, suggesting a steady pullback from recent highs after pronounced volatility. In today's session, the advance of 1.63% signals a technical rebound but the close proximity to support levels suggests near-term uncertainty. Multiple oscillators and momentum readings give mixed signals, with strong trend indications offset by near-term overextension.

Upside favored as bullish signals outweigh short-term risks

For the coming week, the adjusted expected price range is $66.00 to $78.00, ensuring the forecast fits a realistic ±15% band around the current price and accommodates the recent volatility. Considering that all four W1 indicators (RSI, ADX, MACD, MA-50) show a Buy or Strong Buy, there is a very high probability (more than 80%) that TWST will see further upside in the near term, while the probability of a decline is very low. Baseline scenario: TWST moves sideways between $66.00 support and $72.50 resistance as momentum consolidates. Bullish scenario: a break above $72.50 could trigger a test of $78.00, with any move beyond likely limited by proximity to the 52-week high ($80.50). Bearish scenario: a slip below $66.00 brings the $64.27–$60.82 region into play as key support, still well above the 52-week low ($23.30). Overall, upward momentum is strong, but short-term overbought conditions may cause fluctuations before another attempt at the highs.

Earlier, analysts noted that Twist Bioscience was demonstrating strong bullish momentum, driven by positive technical signals and operational progress. This article builds upon that assessment by examining current developments and highlights the importance of monitoring for new trends that could alter the stock's risk-reward outlook.

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.